Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PetMed ExpressPETS +1.87%56 Days Sales Outstanding is 4.02 as of Jun. 2026, which is 24% above its 10-year median of 3.23. GuruFocus rates PETS with a GF Score™ of 56/100 and a GF Value™ of $2.49 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 664 Healthcare Providers & Services companies, PetMed Express ranks better than 96.08% on this metric.
PetMed Express's average Accounts Receivable for the
three
months ended in Jun. 2026 was $1.8 Mil. PetMed Express's Revenue for the
three
months ended in Jun. 2026 was $41.0 Mil.
Hence, PetMed Express's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 4.02.
The historical rank and industry rank for PetMed Express's Days Sales Outstanding or its related term are showing as below:
PETS'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 2.59 Med: 3.23 Max: 4.5
Current: 3.78
During the past 13 years, PetMed Express's highest Days Sales Outstanding was 4.50. The lowest was 2.59. And the median was 3.23.
PETS's Days Sales Outstanding is ranked better than 96.08% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 45.78
vs PETS: 3.78
PetMed Express's Days Sales Outstanding
increased
from Jun. 2025 (3.50) to Jun. 2026 (4.02).
PetMed Express (NAS:PETS) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
PetMed Express Days Sales Outstanding Related Terms
PetMed Express Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for PetMed Express's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PETS vs BHIC, SCNX, PMHS: Days Sales Outstanding Comparison
For the Pharmaceutical Retailers subindustry, PetMed Express's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetMed Express Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where PetMed Express's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PetMed Express (PETS) has a Days Sales Outstanding of 4.02 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on PetMed Express and its competitors. This is 24% above median its historical median of 3.23. Over the past decade, PetMed Express' Days Sales Outstanding has ranged from 2.59 to 4.50. According to the industry distribution chart, PetMed Express ranks #26 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 3.9%.
Is PetMed Express' Days Sales Outstanding too high?
PetMed Express' current Days Sales Outstanding of 4.02 is 24% above median its 10-year median of 3.23. Over the past 10 years, this metric has ranged from a low of 2.59 to a high of 4.50. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.78. PetMed Express' value of 4.02 is 91.2% below this industry median. Based on the distribution chart, PetMed Express ranks #26 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, PetMed Express has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PetMed Express' Days Sales Outstanding compare to BHIC and SCNX?
According to the Healthcare Providers & Services industry distribution chart, PetMed Express ranks #26 out of 664 companies for Days Sales Outstanding. This places PetMed Express in the top 4% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 45.78. PetMed Express' value of 4.02 is 91.2% below this benchmark. Historically, PetMed Express' own Days Sales Outstanding has ranged from 2.59 to 4.50 over the past decade. While the company's 10-year median is 3.23 vs. the industry median of 45.78, PetMed Express has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.78, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PetMed Express's current Days Sales Outstanding of 4.02 is 91.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on PetMed Express and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PetMed Express's current Days Sales Outstanding is 4.02, which is 24% above median its own 10-year median of 3.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetMed Express stock overvalued right now?
Based on GuruFocus' analysis, PetMed Express (PETS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.49, compared to a current price of $1.63 — trading 34.5% below its estimated fair value. The current Days Sales Outstanding is 4.02, which is 24% above median its 10-year median of 3.23 and 91.2% below the Healthcare Providers & Services industry median of 45.78. PetMed Express' overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For PetMed Express (PETS), the current Days Sales Outstanding is 4.02 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PetMed Express (PETS) Overvalued in 2026?
Based on GuruFocus' analysis, PetMed Express stock appears to be undervalued.
The current stock price of $1.63 is trading 34.5% below its estimated GF Value™ of $2.49.
GuruFocus considers PetMed Express to be Possible Value Trap.
Key valuation signals for PETS:
Days Sales Outstanding: 4.02 (24% above median its 10-year median of 3.23)
GF Value™: $2.49 vs. price of $1.63 (34.5% below fair value)
Industry Position: 91.2% below the Healthcare Providers & Services median (#26 of 664)
No single metric tells the full story. See the PETS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
56GF Score
Get the complete analysis for PETS
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETS has been successfully added to your 
